Q1 2014 13F Holders as of 3/31/2014
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
123M
-
Number of holders
-
35
-
Total 13F shares, excl. options
-
10.3M
-
Shares change
-
+1.25M
-
Total reported value, excl. options
-
$23.4M
-
Value change
-
+$2.87M
-
Put/Call ratio
-
1
-
Number of buys
-
21
-
Number of sells
-
-7
-
Price
-
$2.26
Significant Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q1 2014
39 filings reported holding CPRX - CATALYST PHARMACEUTICALS, INC. - COMMON STOCK as of Q1 2014.
CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.3M shares
of 123M outstanding shares and own 8.39% of the company stock.
Largest 10 shareholders include FEDERATED INVESTORS INC /PA/ (3.27M shares), ORBIMED ADVISORS LLC (1.9M shares), VANGUARD GROUP INC (1.63M shares), Opaleye Management Inc. (1.38M shares), BAKER BROS. ADVISORS LP (570K shares), SOPHROSYNE CAPITAL LLC (283K shares), AQR CAPITAL MANAGEMENT LLC (201K shares), Ghost Tree Capital, LLC (200K shares), GEODE CAPITAL MANAGEMENT, LLC (174K shares), and Bank of New York Mellon Corp (123K shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.